Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07892586) titled 'Low-Dose Norepinephrine With Conservative Fluid Therapy in Hepatobiliary Surgery' on Oct. 18.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: Assiut University

Condition: Postoperative Complications Pulmonary Complication

Intervention: Other: Conventional Fluid Therapy Drug: Low-Dose Norepinephrine

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 20, 2026

Target Sample Size: 100

To know more, visit https://clinicaltrials.gov/study/NCT07892586...